All terms in EFO
| Label | Id | Description |
|---|---|---|
| X-linked disease | MONDO_0000425 | [X-linked form of disease.] |
| disorder of peroxisomal transporter | MONDO_0100372 | [Any peroxisomal single enzyme/protein defect that disrupts peroxisomal transport.] |
| genetic dementia | MONDO_0015547 | [Genetic dementia.] |
| adrenal gland disease | EFO_0005539 | [An endocrine system disease that is located_in the adrenal gland., A disease involving the adrenal gland.] |
| neurometabolic disease | MONDO_0019058 | |
| leukodystrophy | MONDO_0019046 | [Leukodystrophies are a group of rare, progressive, metabolic, genetic diseases that affect the brain, spinal cord and often the peripheral nerves. Each type of leukodystrophy is caused by a specific gene abnormality that leads to abnormal development or destruction of the white matter (myelin sheath) of the brain. The myelin sheath is the protective covering of the nerve and nerves can't function normally without it. Each type of leukodystrophy affects a different part of the myelin sheath, leading to a range of neurological problems.] |
| cholesteryl ester 20:4 measurement | EFO_0010348 | [The quantification of cholesteryl ester 20:4 levels in a sample.] |
| cholesteryl ester measurement | EFO_0010351 | [The quantification of cholesteryl ester levels in a sample.] |
| familial hypoaldosteronism | MONDO_0018541 | [Aldosterone synthase deficiency is a rare inherited defect of the final step of aldosterone biosynthesis (conversion of deoxycorticosterone to aldosterone).] |
| hypoaldosteronism disease | MONDO_0015900 | |
| cholesteryl ester 20:5 measurement | EFO_0010349 | [The quantification of cholesteryl ester 20:5 levels in a sample.] |
| PFAPA syndrome | MONDO_0018540 | [An auto inflammatory syndrome characterized by recurrent febrile episodes associated with aphthous stomatitis, pharyngitis and cervical adenitis.] |
| autoinflammatory syndrome | MONDO_0019751 | [A group of disorders of the innate immune system characterized by attacks of seemingly unprovoked inflammation without significant levels of either autoantibodies or autoreactive T cells more characteristic of autoimmune disease.] |
| factor VII activating protease measurement | EFO_0009368 | [Quantification of the amount of factor VII activating protease in a blood sample] |
| lysophosphatidylcholine 16:0 measurement | EFO_0010357 | [The quantification of lysophosphatidylcholine 16:0 levels in a sample.] |
| lysophosphatidylcholine measurement | EFO_0010224 | [A quantification of lysophosphatidylcholines.] |
| GM17117 | CLO_0014950 | [HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100] |
| diffusing capacity of the lung for carbon monoxide | EFO_0009369 | [A measurement of carbon monoxide (CO) transfer from inspired gas to pulmonary capillary blood. During the test, the subject inspires a gas containing CO and one or more tracer gases to allow determination of the gas exchanging capability of the lungs.] |
| respiratory disease biomarker | EFO_0006841 | [The quantitation of a biomarker used in the measurement of lung fuction used in diagnosis or management of a clinical condition.] |
| pulmonary function measurement | EFO_0003892 | [Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc.] |